Wolfgang Steinbrecher

Title: Wolfgang Steinbrecher: Innovator in Cardiovascular Pharmaceuticals

Introduction

Wolfgang Steinbrecher is a notable inventor based in Gundelfingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address cardiovascular diseases. With a total of four patents to his name, Steinbrecher's work has the potential to impact medical treatments significantly.

Latest Patents

Steinbrecher's latest patents include innovative compounds such as 1,6-naphthyridine derivatives. These compounds are designed to treat blood vessel diseases and are characterized by a complex formula that allows for various substitutions, making them versatile in pharmaceutical applications. Another significant patent involves 3-aryl-3-pyrroline derivatives, which demonstrate cardiovascular efficacy and can help manage cardiac insufficiencies. Both patents also include processes for preparation and pharmaceutical compositions that utilize these compounds.

Career Highlights

Throughout his career, Wolfgang Steinbrecher has worked with reputable companies, including Godecke Aktiengesellschaft and Goedecke Aktiengesellschaft. His experience in these organizations has contributed to his expertise in pharmaceutical innovation and development.

Collaborations

Steinbrecher has collaborated with notable colleagues such as Gerhard Satzinger and Manfred F Herrmann. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Wolfgang Steinbrecher's contributions to cardiovascular pharmaceuticals through his innovative patents highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in treatments for blood vessel and cardiac diseases.